Logo Logo
Help
Contact
Switch language to German
Sorafenib response in hepatocellular carcinoma therapy. introducing new possibilities with Cdk5 inhibition
Sorafenib response in hepatocellular carcinoma therapy. introducing new possibilities with Cdk5 inhibition
Not available
Not available
Ardelt, Maximilian
2018
English
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Ardelt, Maximilian (2018): Sorafenib response in hepatocellular carcinoma therapy: introducing new possibilities with Cdk5 inhibition. Dissertation, LMU München: Faculty of Chemistry and Pharmacy
[img]
Preview
PDF
Ardelt_Maximilian.pdf

14MB
[img] ZIP
Ardelt_container.zip

78MB